Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
Alopecia areata (AA) is a chronic heterogeneous inflammatory disease, with unknown pathogenesis. Although there are quite a few options to choose for treatment of AA, there is no specific therapic method, and neither is one therapic method for all patients. In addition, few patients with chronic cou...
Main Author: | Xingqi ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2022-04-01
|
Series: | Pifu-xingbing zhenliaoxue zazhi |
Subjects: | |
Online Access: | http://pfxbzlx.gdvdc.com/CN/10.3969/j.issn.1674-8468.2022.02.001 |
Similar Items
-
Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis
by: Yi Chen, et al.
Published: (2022-11-01) -
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
by: Kinga Kołcz, et al.
Published: (2023-01-01) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01) -
Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01) -
Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)